Supernus Pharmaceuticals SUPN Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's common stock shares issued?
- Supernus Pharmaceuticals (SUPN) reported common stock shares issued of 58M in Q1 2026.
- How has Supernus Pharmaceuticals's common stock shares issued changed year-over-year?
- Supernus Pharmaceuticals's common stock shares issued increased by 3.7% year-over-year, from 56M to 58M.
- What is the long-term trend for Supernus Pharmaceuticals's common stock shares issued?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's common stock shares issued has grown at a 1.6% compound annual growth rate (CAGR), from 53.2M to 57.5M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.